Verastem Oncology Announces New RAMP 201 Molecular Profiling and External Control Arm Analyses Describing Outcomes for Avutometinib Plus Defactinib in Recurrent Low-Grade Serous Ovarian Cancer to be P
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| VERASTEM SHS (NASDAQ: VSTM) | Delayed: 9.99 +0.78 (8.47%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.21 | 52 Week High | $2.43 | |||
| Open | $9.20 | 52 Week Low | $1.05 | |||
| Day High | $10.09 | P/E | N/A | |||
| Day Low | $9.14 | EPS | $-1.79 | |||
| Volume | 5,144,153 | |||||
